A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...

Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...

Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...

Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...

Results from a prospective, multicenter study evaluated the Recana thrombectomy catheter system (InterVene, Inc.) for the ...

Early 30-day results from a prospective, real-world registry of the Abre venous self-expanding stent system (Medtronic) showed ...

Thrombolex, Inc., announced interim results from the first 150 patients enrolled in its RAPID-PE postmarket study, a ...

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., which is developing NeoCast, a ...

BD (Becton, Dickinson and Company) announced 9-month results from the iliac cohort of the AGILITY investigational device ...

B. Braun announced that it will wind down and close the B. Braun Interventional System Inc. (BIS) division. B. Braun stated that ...

Cordis announced that its Selution SLR Sustane percutaneous transluminal angioplasty (PTA) sirolimus drug-eluting balloon ...